Glenmede Trust’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,451
Closed -$342K 1369
2023
Q2
$342K Hold
13,451
﹤0.01% 946
2023
Q1
$342K Buy
13,451
+5,186
+63% +$132K ﹤0.01% 951
2022
Q4
$241K Buy
+8,265
New +$241K ﹤0.01% 1041
2017
Q4
Sell
-117
Closed -$16K 2805
2017
Q3
$16K Buy
+117
New +$16K ﹤0.01% 2042